Doxorubicin-induced toxicity in cardiomyocytes derived from human pluripotent stem cells

Gustav Holmgren1,2, Jane Synnergren1, Yalda Bogestal1*, Caroline Ameen3, Karolina Akesson3, Sandra Holmgren3, Anders Lindahl2, Peter Sartipy1,3§ 1 Systems Biology Research Center, School of Bioscience, University of Skovde, Skovde, Sweden. 2 Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. 3 Takara Bio Europe AB, Gothenburg, Sweden *Current address: SP, Gothenburg, Sweden. §Current address: AstraZeneca Ru0026D, GMD CVMD GMed, Molndal, Sweden